{"entity":{"type":"insider","cik":"0001746298","url":"/insider/0001746298","json_url":"/insider/0001746298.json","name":"Struthers Richard Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":14,"first":"2020-07-17","last":"2026-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Struthers Richard Scott","source":"filing","n_filings":14,"first_seen":"2020-07-17","last_seen":"2026-03-18"}],"transactions":[{"id":6112695,"accession":"0001628280-26-019488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-019488","line_url":"/filing/0001628280-26-019488","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21981.0,"shares_display":"21,981","price_per_share":37.373777808107,"price_display":"37.37","price_state":"stated","total_value":821513.01,"total_display":"821,513.01","total_whole":"821,513","shares_owned_after":413563.0,"shares_owned_after_display":"413,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider","n_lines":2},{"id":4437571,"accession":"0001658247-25-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001658247-25-000011","line_url":"/filing/0001658247-25-000011#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":106000.0,"shares_owned_after_display":"106,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-30","scope":"insider"},{"id":4791457,"accession":"0000950170-25-043401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043401","line_url":"/filing/0000950170-25-043401","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17338.0,"shares_display":"17,338","price_per_share":34.20330834006229,"price_display":"34.20","price_state":"stated","total_value":593016.96,"total_display":"593,016.96","total_whole":"593,017","shares_owned_after":330022.0,"shares_owned_after_display":"330,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider","n_lines":2},{"id":2525479,"accession":"0000950170-24-133297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-133297","line_url":"/filing/0000950170-24-133297#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":57.57,"price_display":"57.57","price_state":"stated","total_value":575700.0,"total_display":"575,700.00","total_whole":"575,700","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2984192,"accession":"0000950170-24-057926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-057926","line_url":"/filing/0000950170-24-057926#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107448.0,"shares_display":"107,448","price_per_share":49.4,"price_display":"49.40","price_state":"stated","total_value":5307931.2,"total_display":"5,307,931.20","total_whole":"5,307,931","shares_owned_after":257485.0,"shares_owned_after_display":"257,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-08","filed_date":"2024-05-10","scope":"insider"},{"id":2949799,"accession":"0000950170-24-042681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-042681","line_url":"/filing/0000950170-24-042681#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40951.0,"shares_display":"40,951","price_per_share":49.17,"price_display":"49.17","price_state":"stated","total_value":2013560.67,"total_display":"2,013,560.67","total_whole":"2,013,561","shares_owned_after":237835.0,"shares_owned_after_display":"237,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":8609486,"accession":"0001209191-23-054567","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-054567","line_url":"/filing/0001209191-23-054567#line-4","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":199082.0,"shares_display":"199,082","price_per_share":30.56,"price_display":"30.56","price_state":"stated","total_value":6083945.92,"total_display":"6,083,945.92","total_whole":"6,083,946","shares_owned_after":135522.0,"shares_owned_after_display":"135,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-06","scope":"insider"},{"id":8609481,"accession":"0001209191-23-054567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-054567","line_url":"/filing/0001209191-23-054567#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":918.0,"shares_display":"918","price_per_share":29.95,"price_display":"29.95","price_state":"stated","total_value":27494.1,"total_display":"27,494.10","total_whole":"27,494","shares_owned_after":135522.0,"shares_owned_after_display":"135,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-06","scope":"insider"},{"id":8546107,"accession":"0001209191-23-042229","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-042229","line_url":"/filing/0001209191-23-042229#line-3","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14157.0,"shares_display":"14,157","price_per_share":20.35,"price_display":"20.35","price_state":"stated","total_value":288094.95,"total_display":"288,094.95","total_whole":"288,095","shares_owned_after":630805.0,"shares_owned_after_display":"630,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-13","scope":"insider"},{"id":8546104,"accession":"0001209191-23-042229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042229","line_url":"/filing/0001209191-23-042229#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11459.0,"shares_display":"11,459","price_per_share":20.17,"price_display":"20.17","price_state":"stated","total_value":231128.03,"total_display":"231,128.03","total_whole":"231,128","shares_owned_after":644962.0,"shares_owned_after_display":"644,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-13","scope":"insider"},{"id":8546097,"accession":"0001209191-23-042229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042229","line_url":"/filing/0001209191-23-042229#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24384.0,"shares_display":"24,384","price_per_share":20.14,"price_display":"20.14","price_state":"stated","total_value":491093.76,"total_display":"491,093.76","total_whole":"491,094","shares_owned_after":656421.0,"shares_owned_after_display":"656,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":8629445,"accession":"0001209191-23-038851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038851","line_url":"/filing/0001209191-23-038851#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":20.81,"price_display":"20.81","price_state":"stated","total_value":1040500.0,"total_display":"1,040,500.00","total_whole":"1,040,500","shares_owned_after":680805.0,"shares_owned_after_display":"680,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-21","scope":"insider"},{"id":6543339,"accession":"0001209191-22-024531","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-024531","line_url":"/filing/0001209191-22-024531","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138643.0,"shares_display":"138,643","price_per_share":26.828801185058026,"price_display":"26.83","price_state":"stated","total_value":3719625.4827,"total_display":"3,719,625.48","total_whole":"3,719,625","shares_owned_after":730805.0,"shares_owned_after_display":"730,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-13","filed_date":"2022-04-15","scope":"insider","n_lines":3},{"id":6920725,"accession":"0001209191-22-023722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023722","line_url":"/filing/0001209191-22-023722#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21357.0,"shares_display":"21,357","price_per_share":25.3418,"price_display":"25.34","price_state":"stated","total_value":541224.8226,"total_display":"541,224.82","total_whole":"541,225","shares_owned_after":869448.0,"shares_owned_after_display":"869,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-07","scope":"insider"},{"id":5478274,"accession":"0001209191-21-055312","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-055312","line_url":"/filing/0001209191-21-055312","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":90000.0,"shares_owned_after_display":"90,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider","n_lines":3},{"id":3095615,"accession":"0001209191-20-061822","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-061822","line_url":"/filing/0001209191-20-061822#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":13.1,"price_display":"13.10","price_state":"stated","total_value":52400.0,"total_display":"52,400.00","total_whole":"52,400","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-04","scope":"insider"},{"id":3095611,"accession":"0001209191-20-061822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-061822","line_url":"/filing/0001209191-20-061822#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.6,"price_display":"12.60","price_state":"stated","total_value":12600.0,"total_display":"12,600.00","total_whole":"12,600","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-04","scope":"insider"},{"id":3046153,"accession":"0001209191-20-042897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042897","line_url":"/filing/0001209191-20-042897#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":14.4633,"price_display":"14.46","price_state":"stated","total_value":253107.75,"total_display":"253,107.75","total_whole":"253,108","shares_owned_after":890805.0,"shares_owned_after_display":"890,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-16","filed_date":"2020-07-17","scope":"insider"},{"id":3046150,"accession":"0001209191-20-042897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-042897","line_url":"/filing/0001209191-20-042897#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001746298","owner_name":"Struthers Richard Scott","owner_display_name":"Struthers Richard Scott","owner_url":"/insider/0001746298","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":15.2984,"price_display":"15.30","price_state":"stated","total_value":267722.0,"total_display":"267,722.00","total_whole":"267,722","shares_owned_after":908305.0,"shares_owned_after_display":"908,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001658247","name":"Crinetics Pharmaceuticals, Inc.","url":"/issuer/0001658247","role":"Director, Officer (President & CEO)","n_filings":14,"first_seen":"2020-07-17","last_seen":"2026-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001746298","retrieved_at":"2026-08-27T02:44:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}